See LEGEND for key to shading and symbols.
Subject Area - PHAR Term - Term 3 2020
| PHAR2011 | PHAR3101 | PHAR9104 | PHAR9117 | PHAR9118 | PHAR9121 |
| PHAR9124 |
Data is correct as at Sun 27 Sep 20:50:36 AEST 2020
| Comp | Sect | Class | Type | Status | Enr/Cap | % Full | Times (weeks, Location) - default 1hour |
| PHAR2011 | Introductory Pharmacology and | ||||||
| CRS | CR01 | 2330 | Open | 0/7 | 0% | (Course Enrolment, UGRD) | |
| LAB | T10A | 5300 | Enr | Open | 139/140 | 99% | Tue 10-13 (w1-5, Wurth 115); Tue 10-13 (w7-10, Online) |
| LAB | T14A | 5301 | Enr | Open | 134/140 | 96% | Tue 14-17 (w1-5, Wurth 115); Tue 14-17 (w7-10, Online) |
| LEC | A | 5291 | Rel | Open | 273/280 | 98% | Mon 17# (w1-3,5,7-10, Online); Fri 09# (w1-5,7-10, Online) |
| TUT | F10A | 5292 | Rel | Open | 34/35 | 97% | Fri 10 (w1-5,7-10, Online) |
| TUT | F10B | 5293 | Rel | Full | 35/35 | 100% | Fri 10 (w1-5,7-10, Online) |
| TUT | F11A | 5294 | Rel | Open | 33/35 | 94% | Fri 11 (w1-5,7-10, Online) |
| TUT | F11B | 5295 | Rel | Open | 34/35 | 97% | Fri 11 (w1-5,7-10, Online) |
| TUT | F13A | 5296 | Rel | Open | 33/35 | 94% | Fri 13 (w1-5,7-10, Online) |
| TUT | F13B | 5297 | Rel | Open | 33/35 | 94% | Fri 13 (w1-5,7-10, Online) |
| TUT | F15A | 5298 | Rel | Full | 36/35 | 100% | Fri 15 (w1-5,7-10, Online) |
| TUT | F15B | 5299 | Rel | Full | 35/35 | 100% | Fri 15 (w1-5,7-10, Online) |
| PHAR3101 | Drug Discovery, Design & Devel | ||||||
| CRS | CR01 | 2471 | Open | 0/6 | 0% | (Course Enrolment, UGRD) | |
| LAB | M11A | 6084 | Rel | Open | 70/76 | 92% | Mon 11-14 (w1-3,5,7-10, Online) |
| LEC | A | 6081 | Enr | Open | 70/76 | 92% | Tue 09# (w1-5,7-10, Online); Wed 13# (w1-5,7-10, Online) |
| TUT | F13A | 6082 | Rel | Open | 34/38 | 89% | Fri 13 (w1-5,7-10, Online) |
| TUT | F14A | 6083 | Rel | Open | 36/38 | 95% | Fri 14 (w1-5,7-10, Online) |
| PHAR9104 | Regulatory Affairs | ||||||
| CRS | CR01 | 1250 | Open | 0/8 | 0% | (Course Enrolment, PGRD) | |
| DST | A | 10042 | Enr | Open | 37/45 | 82% | |
| PHAR9117 | Cancer Therapeutics | ||||||
| CRS | CR01 | 1717 | Open | 0/10 | 0% | (Course Enrolment, PGRD) | |
| DST | A | 10043 | Enr | Open | 20/30 | 67% | |
| PHAR9118 | Therapeutics | ||||||
| CRS | CR01 | 1132 | Tent | 0/0 | N/A | (Course Enrolment, PGRD) | |
| DST | DST1 | 9749 | Enr | Canc | 0/0 | N/A | |
| PHAR9121 | Pharmacovigilance | ||||||
| CRS | CR01 | 1054 | Open | 0/1 | 0% | (Course Enrolment, PGRD) | |
| DST | A | 10044 | Enr | Open | 49/50 | 98% | |
| PHAR9124 | Internship | ||||||
| CRS | CR01 | 1448 | Closed* | 0/5 | 0% | (Course Enrolment, PGRD) | |
| ^ top ^ | |||||||
| LEGEND | |||||||
| * This class requires consent. Students cannot self-enrol. | |||||||
| # Timetable clash allowed. | |||||||
| /odd Runs in odd weeks only. /even Runs in even weeks only. | |||||||
| Comb/w Jointly taught with corresponding class(es) for specified course(s). Capacity shown is effective capacity. | |||||||
| Effective capacity is the class capacity less any places taken by students in the other jointly-taught classes. | |||||||
| [ ] Class capacity where different from effective capacity. | |||||||
| Shaded cells: | LEC | Activity different from previous | |||||
| Stop | Status is Stop Further Enrolment, Tentative, Closed or Cancelled | ||||||
| 100% | Class is full (> 100% means capacity is exceeded) | ||||||
| 80% | Class is nearly full (80% or more) | ||||||
| 50% | Class is half full | ||||||
| 0% | Class is less than half full | ||||||
| UNSW Sydney NSW 2052, Australia Telephone: (within Aust.) 02 9385 1000, (International) +61 2 9385 1000 CRICOS Provider Code 00098G ABN: 57 195 873 179 Authorised by Vice-President and Deputy Vice-Chancellor (Academic) Privacy Policy Copyright & Disclaimer Accessibility |